Davis Rea’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.6M | Buy |
43,294
+5,582
| +15% | +$2.27M | 4.36% | 6 |
|
|
2025
Q1 | $18.8M | Buy |
37,712
+8,452
| +29% | +$4.21M | 5% | 6 |
|
|
2024
Q4 | $15.2M | Buy |
29,260
+17,231
| +143% | +$8.97M | 7.71% | 3 |
|
|
2024
Q3 | $7.45M | Sell |
12,029
-4,972
| -29% | -$3.08M | 3.24% | 14 |
|
|
2024
Q2 | $9.41M | Sell |
17,001
-2,432
| -13% | -$1.35M | 4.7% | 9 |
|
|
2024
Q1 | $11.3M | Sell |
19,433
-427
| -2% | -$248K | 5.15% | 9 |
|
|
2023
Q4 | $10.5M | Buy |
19,860
+4,331
| +28% | +$2.3M | 5.4% | 6 |
|
|
2023
Q3 | $7.87M | Buy |
15,529
+19
| +0.1% | +$9.62K | 4.26% | 8 |
|
|
2023
Q2 | $8.1M | Buy |
15,510
+4,964
| +47% | +$2.59M | 4.54% | 7 |
|
|
2023
Q1 | $6.08M | Sell |
10,546
-180
| -2% | -$104K | 3.67% | 11 |
|
|
2022
Q4 | $5.91M | Sell |
10,726
-120
| -1% | -$66.1K | 3.7% | 11 |
|
|
2022
Q3 | $5.5M | Sell |
10,846
-10,874
| -50% | -$5.52M | 3.53% | 11 |
|
|
2022
Q2 | $11.8M | Buy |
21,720
+6,351
| +41% | +$3.45M | 3.51% | 10 |
|
|
2022
Q1 | $5.12M | Buy |
15,369
+7,766
| +102% | +$2.59M | 2.48% | 17 |
|
|
2021
Q4 | $5.08M | Buy |
7,603
+24
| +0.3% | +$16K | 2.36% | 18 |
|
|
2021
Q3 | $4.33M | Buy |
7,579
+10
| +0.1% | +$5.72K | 2.12% | 20 |
|
|
2021
Q2 | $3.82M | Buy |
7,569
+121
| +2% | +$61.1K | 1.9% | 21 |
|
|
2021
Q1 | $3.4M | Buy |
7,448
+664
| +10% | +$303K | 1.82% | 21 |
|
|
2020
Q4 | $3.16M | Buy |
6,784
+170
| +3% | +$79.2K | 1.78% | 24 |
|
|
2020
Q3 | $2.92M | Buy |
6,614
+87
| +1% | +$38.4K | 1.96% | 20 |
|
|
2020
Q2 | $2.37M | Sell |
6,527
-37
| -0.6% | -$13.4K | 1.8% | 22 |
|
|
2020
Q1 | $1.86M | Buy |
6,564
+155
| +2% | +$44K | 1.8% | 22 |
|
|
2019
Q4 | $2.08M | Buy |
6,409
+254
| +4% | +$82.6K | 1.42% | 26 |
|
|
2019
Q3 | $1.79M | Buy |
6,155
+1,244
| +25% | +$363K | 1.31% | 26 |
|
|
2019
Q2 | $1.44M | Buy |
+4,911
| New | +$1.44M | 0.83% | 36 |
|